Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors APMA Annual Scientific Meeting

Ads

You May Also Like

Cesca Therapeutics Announces Reduction in Operating Expenses

RANCHO CORDOVA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or ...

Curetis initiates U.S. FDA study for Unyvero Invasive Joint Infections Cartridge

Curetis initiates U.S. FDA study for Unyvero Invasive Joint Infections Cartridge Initial patient samples ...